Meeting
2023 ASCO Annual Meeting
Clinical validation of an activity-based enzyme assay for early stage lung cancer.
Authors
Paul W. Dempsey
Hawkeye Bio, Inc., Torrance, CA
Paul W. Dempsey , Cristina-Mihaela Sandu Aparicio , Ricardo Gonzalezirias , Spencer Hantula , Mari Kagawa , Stefan H. Bossmann , Obdulia Covarrubias-Zambrano , Alykhan S. Nagji , Nirmal K Veeramachaneni , Nezih O. Ermerak , Derya Kocakaya , Tunc Lacin , Bedrettin Yildizeli , Sara Witting Christensen Wen , Line Nederby , Torben Hansen , Ole Hilberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8533)
DOI
10.1200/JCO.2023.41.16_suppl.8533
Abstract #
8533
Poster Bd #
160
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Simulating the cost-effectiveness of lung cancer screening by low-dose CT scan in Canada.
First Author: John R. Goffin
Poster
2022 ASCO Quality Care Symposium
Lessons learned from a lung cancer screening patient navigation program at a safety-net hospital system.
First Author: Andrea R Semlow
Poster
2021 ASCO Annual Meeting
One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst Hispanic/LatinX and African Americans.
First Author: Coral Olazagasti
Poster
2020 ASCO Quality Care Symposium
Differences in rates of low-dose computed tomography screening for lung cancer amongst various outpatient care centers.
First Author: Lukas Delasos